Arcus Biosciences, Inc. (RCUS)
29.21
-1.38
(-4.51%)
USD |
NYSE |
Aug 28, 16:00
29.18
-0.03
(-0.10%)
After-Hours: 20:00
Arcus Biosciences 1 Year Total Returns (Daily) : 175.3% for Aug. 28, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 28, 2026 | 175.3% |
| August 27, 2026 | 189.7% |
| August 26, 2026 | 196.3% |
| August 25, 2026 | 211.0% |
| August 24, 2026 | 186.0% |
| August 21, 2026 | 189.5% |
| August 20, 2026 | 192.6% |
| August 19, 2026 | 201.7% |
| August 18, 2026 | 181.9% |
| August 17, 2026 | 184.5% |
| August 14, 2026 | 197.5% |
| August 13, 2026 | 186.9% |
| August 12, 2026 | 199.5% |
| August 11, 2026 | 213.8% |
| August 10, 2026 | 217.0% |
| August 07, 2026 | 208.4% |
| August 06, 2026 | 198.5% |
| August 05, 2026 | 190.1% |
| August 04, 2026 | 212.0% |
| August 03, 2026 | 201.5% |
| July 31, 2026 | 208.8% |
| July 30, 2026 | 199.6% |
| July 29, 2026 | 175.2% |
| July 28, 2026 | 174.6% |
| July 27, 2026 | 172.1% |
| Date | Value |
|---|---|
| July 24, 2026 | 187.9% |
| July 23, 2026 | 204.9% |
| July 22, 2026 | 227.2% |
| July 21, 2026 | 218.4% |
| July 20, 2026 | 207.9% |
| July 17, 2026 | 190.6% |
| July 16, 2026 | 187.7% |
| July 15, 2026 | 210.3% |
| July 14, 2026 | 193.6% |
| July 13, 2026 | 200.9% |
| July 10, 2026 | 203.1% |
| July 09, 2026 | 221.1% |
| July 08, 2026 | 256.0% |
| July 07, 2026 | 268.0% |
| July 06, 2026 | 254.0% |
| July 02, 2026 | 253.1% |
| July 01, 2026 | 245.9% |
| June 30, 2026 | 278.7% |
| June 29, 2026 | 290.9% |
| June 26, 2026 | 264.7% |
| June 25, 2026 | 250.9% |
| June 24, 2026 | 229.1% |
| June 23, 2026 | 226.5% |
| June 22, 2026 | 215.9% |
| June 18, 2026 | 185.7% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Halozyme Therapeutics, Inc. | 44.69% |
| AVITA Medical, Inc. | 136.3% |
| Iovance Biotherapeutics, Inc. | 259.2% |
| Editas Medicine, Inc. | 19.25% |
| Recursion Pharmaceuticals, Inc. | -31.35% |